Market News
Merck Acquires Terns Pharmaceuticals in $6.7 Billion Deal to Strengthen Cancer Pipeline
Merck just dropped $6.7 billion on a biotech firm developing a promising new cancer therapy for a rare blood disorder....
25/03/2026
5 views